About Affimed (AFMD)
Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company's product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research t... Read more
- USD4.88
- USD4.89
- USD4.56
- USD11.10
- -2.20%
- 9M
- 49.94k
- 110.05k
- 78M
- 2.24
- -40.90%
Stock News
1 hour ago
Anglo American does not find BHP $39 billion offer attractive, sources say
Yahoo
1 hour ago
CEOs are quitting at record rates, and women are twice as likely as men to leave
CNBC
1 hour ago
Stocks are tumbling. But these 2 portfolio holdings should be defying the slide
CNBC
1 hour ago
Schneider Electric Releases All-In-One Battery Energy Storage System for Microgrids
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
